Anti- tuberculosis activities of medicinal plants used in the treatment of tuberculosis in HIV patients in Nigeria

被引:0
作者
Anochie, P., I [1 ]
Onyejepu, N. [1 ]
Ogu, A. C. [2 ]
Adetunji, M. A. [1 ]
Efere, L. O. [1 ]
Onyeozirila, A. C. [3 ]
Onyeneke, E. C. [4 ]
Onyeneke, C. N. [5 ]
Obinna, J. U.
Srikanth, A. [6 ]
Bueno, J. [7 ]
机构
[1] Nigerian Inst Med Res, Lagos, Nigeria
[2] Univ Sheffield, Dept Med, Sheffield S10 2TN, S Yorkshire, England
[3] Madonna Univ, Dept Med, Elele, Rivers State, Nigeria
[4] Fed Med Ctr, Owerri, Imo State, Nigeria
[5] Abia State Univ, Dept Microbiol, Uturu, Abia State, Nigeria
[6] VIT Univ, Sch Biosci Technol, Vellore, Tamil Nadu, India
[7] Inst Nacl Salud, Grp Micobacterias, Bogota, DC, Colombia
关键词
Anti-tuberculosis; activity; medicinal plants; treatment; HIV patients; Nigeria;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Local herbalists in Nigeria claimed that extracts of certain parts, that is, stem and seeds obtained from Crinum glaucum, Treculia africana, Erythrina mildbaedi, Ficus thonningii and Xylopis aethiopica are used to treat tuberculosis patients. We conducted a laboratory-based study of this claim scientifically using the procedures employed by the local herbalists. The Mycobacterium tuberculosis strain used in this study was obtained locally and characterized based on cultural and biochemical tests on isolates of bacteriologically proven tuberculosis positive patients. The M. tuberculosis strains were found resistant to all the extracts. There was no growth on the isoniazid drug containing medium which was used as control. There was growth on all the LJ medium containing the extracts. The results of these findings shows that the extracts of these plants exhibited no significant anti-microbial activity against M. tuberculosis and therefore not recommendable for clinical use as an anti-tuberculosis drug.
引用
收藏
页码:1126 / 1130
页数:5
相关论文
共 8 条
[1]  
BHAKUNI DS, 1974, LLOYDIA, V37, P621
[2]  
BOAKYEYIADOM K, 1977, LAM Q J CRUDE DRUG R, V15, P201
[3]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[4]  
CURTIN ME, 1983, BIO-TECHNOL, V1, P649
[5]  
HANS LR, 1998, MINIMUM REQUIREMENT, P72
[6]  
INDERLIED C, 1993, ANTIMICROBIAL AGENTS, P1385
[7]  
Malcolm S A, 1969, Lloydia, V32, P512
[8]  
SAKUMA T, 1967, Annals of the Phytopathological Society of Japan, V33, P48